Briefly, each sample pool was loaded in one lane of Single Cell A Chip (10X Genomics, 120236), and the single-cell RNA ... material and for the scientific discussions. We thank K. Mc Intyre for ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.29. Operator: Thank you for standing by. My name ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the life science tools and diagnostics group to be down ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

"This is a win for the research community," the company's the CEO says. The lawsuit against the company was filed in August 2022. Seattle-based Parse Biosciences secured another major legal ...

SAN FRANCISCO/NEW YORK, Feb 10 (Reuters) - OpenAI is pushing ahead on its plan to reduce its reliance on Nvidia (NVDA.O), opens new tab for its chip supply by developing its first generation of in ...

Genomics is the study of the full genetic complement of an organism (the genome). It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the ...

Blue chip stocks offer stability and dividends, ideal for both conservative and risk-tolerant investors. Top blue chip stocks like Apple and Berkshire Hathaway dominate their industries with ...

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...